About this trial
this study will be conducted to investigate the effect of artificial intelligence (AI) based cognitive training on sleep disorders and quality of life in patients with multiple sclerosis.
Eligibility criteria
Qualifiers
Patient's age ranges from 25-40 years.
Patient with EDSS not more than 5.
Patients who have no relapses for the previous three months.
Patients with sufficient cognitive abilities that enables them to understand and follow
Disqualifiers
Mechanical or neuromascular problems.
Cardiovascular problems (unstable angina, recent myocardial infarction within the last three months, congestive heart failure, significant heart valve dysfunction, or unstable hypertension) or pulmonary disorders.
Auditory problems.
Sensory impairment caused by other diseases except the MS such as diabetes mellitus.
Trial design
Treatments tested in this trial
- cognitive Therapy by artificial intillegence
- designed physical-therapy program